Savara, Inc. (SVRA)
5.35
+0.12
(+2.29%)
USD |
NASDAQ |
Feb 10, 10:45
Savara EPS Diluted (Quarterly) : -0.1366 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| ADMA Biologics, Inc. | 0.1489 |
| ACADIA Pharmaceuticals, Inc. | 0.4206 |
| Alnylam Pharmaceuticals, Inc. | 1.840 |
| BioMarin Pharmaceutical, Inc. | -0.1601 |
| Imunon, Inc. | -1.165 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -29.56M |
| Total Expenses (Quarterly) | 29.56M |
| Enterprise Value | 969.58M |
| Earnings Yield | -10.00% |
| Normalized Earnings Yield | -9.970 |